Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 6,610,327

« Back to Dashboard

Which drugs does patent 6,610,327 protect, and when does it expire?

Patent 6,610,327 protects AVELOX and is included in one NDA. There are three tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

This patent has forty-six patent family members in thirty-nine countries.

Summary for Patent: 6,610,327

Title: Pharmaceutical moxifloxacin preparation
Abstract:The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.
Inventor(s): Bosche; Patrick (Odenthal, DE), Mahler; Hans Friedrich (Koln, DE), Weisemann; Claus (Apex, NC)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:09/830,770
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bayer Hlthcare
moxifloxacin hydrochloride
TABLET;ORAL021085-001Dec 10, 1999RXYesYes6,610,327► SubscribeY METHOD OF COMBATING BACTERIA IN A PATIENT
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,610,327

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany198 55 758Nov 10, 1998
PCT Information
PCT FiledOctober 29, 1999PCT Application Number:PCT/EP99/08230
PCT Publication Date:May 18, 2000PCT Publication Number: WO00/27398

International Patent Family for Patent: 6,610,327

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1149993► Subscribe
Colombia5070571► Subscribe
Cuba23260► Subscribe
Czech Republic20011652► Subscribe
Czech Republic292069► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.